Proceeds will go toward R&D initiatives, the commercialization of the Icell8 single-cell system, and general corporate and working capital purposes.
The firm expects to raise net proceeds of $13.6 million, which it will use to advance development and commercialization of its single-cell genomics products.
The company launched the BD FACSseq flow cytometer and BD Precise Assays for high-throughput single-cell gene-expression analysis studies at the ASHG annual meeting.
The company reported preliminary Q3 revenue growth of between 52 percent and 68 percent, and raised its revenue guidance for full-year 2015.
Proceeds from the offering will go toward R&D and commercialization efforts around its single-cell products, sales and marketing, and general corporate and working capital purposes.
The company plans to use the proceeds for general corporate and working capital purposes including commercialization activities intended to increase revenue.
The firm's revenues dipped as it awaits the launch of its single-cell business, which should become its primary focus after 2015.
The company continues to expect its single-cell analysis platform will launch by year-end.
The company continues to expect its SmartChip single-cell analysis platform will launch by the end of the year.
The companies will validate the technology for isolating single cells from various tissues and preparing libraries for next-generation sequencing.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.